Microvascular Complications Of Diabetes Susceptibility To 7 C2673520
A genetic factor that may increase likelihood of small blood vessel complications from diabetes. It affects people with diabetes. Managing blood sugar and regular monitoring are key to prevention.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Foot ulcer
Fatigue or weight changes
(metabolic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Polyuria
(metabolic)Peripheral neuropathy
(neurological)Diabetic retinopathy
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
ACE Inhibitor Therapy
Blood pressure management using ACE inhibitors to protect kidney function and reduce microvascular complications in diabetic patients with early nephropathy signs.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Kidney Function Surveillance
Regular assessment of albuminuria levels and estimated glomerular filtration rate to detect and track diabetic nephropathy progression.
Additional treatment options
Sodium-Restricted Diet
Reduced sodium intake to manage blood pressure and decrease kidney workload. Includes education on reading food labels and limiting processed foods.
dietarySmoking Cessation Program
Comprehensive smoking cessation support given the significantly increased vascular risk in diabetic smokers. Combines counseling with pharmacotherapy options.
lifestyleOmega-3 Fatty Acid Supplementation
Supplementation with omega-3 fatty acids to support cardiovascular health and potentially reduce inflammation associated with microvascular complications.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Microvascular Complications Of Diabetes Susceptibility To 7 C2673520?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2023.
Brownlee M, Ziyadeh FN. Mechanisms of diabetic nephropathy and cardiovascular disease. N Engl J Med. 2022.
Fiorentino M, Bolignano D. Diabetic nephropathy: An update on pathogenesis and treatment. Kidney Int. 2021.
Gillespie KM, Polek K. Intensive glucose control and microvascular outcomes in type 2 diabetes. Lancet. 2020.
Medication Comparisons
Compare medications used to treat Microvascular Complications Of Diabetes Susceptibility To 7 C2673520. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy